Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.050
-0.010 (-0.49%)
At close: May 18, 2026, 4:00 PM EDT
2.050
0.00 (0.00%)
After-hours: May 18, 2026, 4:10 PM EDT
Annovis Bio Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Annovis Bio stock has a consensus rating of "Buy" and an average price target of $12.5. The average 1-year stock price forecast is 509.76% higher than the current stock price, while the lowest is $8.00 (+290.24%) and the highest is $17 (+729.27%).
Price Target: $12.5 (+509.76%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 14, 2026.
Analyst Ratings
The average analyst rating for Annovis Bio stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +729.27% | Apr 14, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +729.27% | Sep 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +387.80% | Sep 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $12 | Strong Buy | Maintains | $30 → $12 | +485.37% | Jun 9, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $26 → $17 | Strong Buy | Maintains | $26 → $17 | +729.27% | May 15, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.30
from -1.40
EPS Next Year
-1.35
from -1.30
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -1.20 | -1.34 | ||||||
| Avg | -1.30 | -1.35 | ||||||
| Low | -1.37 | -1.33 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.